APA (7th ed.) Citation

Bulbul, M. V., Mermer, A., Kolbasi, B., Kocabas, F., Kalender, S. M., Kirectepe Aydin, K. A., . . . Keskin, İ. (2024). mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells. Pharmaceuticals (14248247), 17(12), 1562. https://doi.org/10.3390/ph17121562

Chicago Style (17th ed.) Citation

Bulbul, Muhammet Volkan, Arif Mermer, Bircan Kolbasi, Fatih Kocabas, Semiha Mervenur Kalender, Kiymet Asli Kirectepe Aydin, Turan Demircan, and İlknur Keskin. "MTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells." Pharmaceuticals (14248247) 17, no. 12 (2024): 1562. https://doi.org/10.3390/ph17121562.

MLA (9th ed.) Citation

Bulbul, Muhammet Volkan, et al. "MTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells." Pharmaceuticals (14248247), vol. 17, no. 12, 2024, p. 1562, https://doi.org/10.3390/ph17121562.